- Mayke B G Koek, research fellow dermatology1,
- Erik Buskens, professor of medical technology assessment2,
- Carla AFM Bruijnzeel-Koomen, professor of dermatology/allergology1,
- Vigfús Sigurdsson, dermatologist1
- 1University Medical Centre Utrecht, 3584 CX Utrecht, Netherlands
- 2Department of Epidemiology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands
- author{at}koek.com
Cameron and Dawe suggest that careful selection of patients is essential to maintain and safeguard efficacy and safety, seeming to think that patients in our trial were also specifically selected.1 However, our patients were a representative sample of those considered clinically eligible. …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Ventilator associated pneumonia
Published 30 May 2012
Re: Restless legs syndrome
Published 30 May 2012
Author's reply
Published 30 May 2012
Re: Full access to trial data holds many benefits and a few pitfalls, conference hears
Published 30 May 2012
Restless Legs Syndrome: Fact or Fiction
Published 30 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27